CASE STUDY. UNI-494 drug Mechanism of Action for Unicycive Therapeutics (NAS: UNCY)
See a full case study:
https://visual-science.com/projects/drug-mechanism-of-action-animation-uni-494
Видео CASE STUDY. UNI-494 drug Mechanism of Action for Unicycive Therapeutics (NAS: UNCY) канала Visual Science
https://visual-science.com/projects/drug-mechanism-of-action-animation-uni-494
Видео CASE STUDY. UNI-494 drug Mechanism of Action for Unicycive Therapeutics (NAS: UNCY) канала Visual Science
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
CASE STUDY. Mechanism of Technology and Device Animations. Apton Biosystems
Scientific animation for drug-hunting platform. Scorpion Therapeutics
3D animation-presentation type
MoA animation for Redpin Therapeutics' IR and corporate communication.
MoA animation for Atsena Therapeutics' investor deck and website
Atsena Therapeutics: Dual Vector animation. MoA animation
Neoleukin NL-201 MoA animation. De novo protein development platform
Quantitative Amplicon Sequencing (QASeq) NUPROBE 3D animation by Visual-Science
pH-Low Insertion Peptide Platform Technology for targeted delivery
High-end real-time AR application: Zika virus AR mode
High-end real- time AR application: Rhinovirus AR model
High-end real-time AR application: Immunoglobulin G
Visual Cortex Activation. 3D animation for holographic projection
3D model of the SARS-CoV-2 virus at atomic resolution
Identification of target DNA sequences by Lac repressor and CRISPR-Cas9 complex
Anti-hypoxia Therapy — Mechanism of Action (MOA)
Cybrexa Therapeutics Tumor Specific Drugs Mechanism of Action (MOA)
Visual Science Short Medical Reel — Early 2017
Curaxin MOA Animation for Roswell Park Cancer Institute
HIV Scientifically Accurate 3D Model